Literature DB >> 30947384

Chronic Kidney Disease After Liver Transplantation: Impact of Extended Criteria Grafts.

Marit Kalisvaart1,2, Andrea Schlegel1, Palak J Trivedi1,3, Keith Roberts1, Darius F Mirza1, Thamara Perera1, John I Isaac1, James Ferguson1,3, Jeroen de Jonge2, Paolo Muiesan1.   

Abstract

The use of extended criteria donor (ECD) grafts has been associated with acute kidney injury (AKI) after liver transplantation. However, the relation between graft quality and development of chronic kidney disease (CKD) remains unknown. Therefore, the aim of this study was to analyze the impact of ECD grafts for CKD after liver transplantation. All patients (2007-2015) transplanted for end-stage liver disease at our center were assessed. Longterm kidney function was divided into 4 groups: no CKD (estimated glomerular filtration rate [eGFR], ≥60 mL/minute/1.73 m2 ), mild CKD (eGFR, 30-59 mL/minute/1.73 m2 ), severe CKD (eGFR, 15-29 mL/minute/1.73 m2 ), and end-stage renal disease (ESRD). Marginal donation after brain death (DBD) grafts (donor age, >70 years; body mass index, >35 kg/m2 ; cold storage, >12 hours) and donation after circulatory death (DCD) grafts were considered ECD grafts. Overall, 926 patients were included, and 43% received an ECD graft (15% marginal DBD; 28% DCD). After 5 years, 35% developed CKD; severe CKD and ESRD occurred in only 2% and 1%, respectively. CKD rates were comparable for all 3 graft groups (standard group, 36%; marginal DBD group, 29%; DCD group, 35%; standard versus marginal DBD groups, P = 0.16; standard versus DCD group, P = 0.80). None of the ECD criteria were identified as independent risk factors in a Cox regression model for CKD. Risk factors included recipient age, female sex, and preoperative kidney function. Furthermore, recipients who had severe acute kidney injury (AKI; Kidney Disease: Improving Global Outcomes stages 2 and 3) had a 1.8-fold increased risk for CKD. Longterm kidney function of recipients with severe AKI depended on the recovery of kidney function in the first postoperative week. In conclusion, there is no direct relation between the use of ECD grafts and CKD after liver transplantation. However, caution should be taken in recipients who experience severe AKI, regardless of graft type.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 30947384     DOI: 10.1002/lt.25468

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation.

Authors:  Yi-Chia Chan; Cheng-Hsi Yeh; Lung-Chih Li; Chao-Long Chen; Chih-Chi Wang; Chih-Chi Lin; Aldwin D Ong; Ting-Yu Chiou; Chee-Chien Yong
Journal:  J Clin Med       Date:  2022-05-30       Impact factor: 4.964

2.  Development and validation of a nomogram for predicting acute kidney injury after orthotopic liver transplantation.

Authors:  Dandan Guo; Huifang Wang; Xiaoying Lai; Junying Li; Demin Xie; Li Zhen; Chunhui Jiang; Min Li; Xuemei Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Prediction of chronic kidney disease after orthotopic liver transplantation: development and validation of a nomogram model.

Authors:  Dandan Guo; Huifang Wang; Jun Liu; Hang Liu; Ming Zhang; Zixuan Fu; Xuemei Liu
Journal:  BMC Nephrol       Date:  2022-01-16       Impact factor: 2.388

4.  Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month.

Authors:  Deok-Gie Kim; Shin Hwang; Jong Man Kim; Je Ho Ryu; Young Kyoung You; Donglak Choi; Bong-Wan Kim; Dong-Sik Kim; Yang Won Nah; Tae-Seok Kim; Jai Young Cho; Geun Hong; Jae Do Yang; Jaryung Han; Suk-Won Suh; Kwan Woo Kim; Yun Kyung Jung; Ju Ik Moon; Jun Young Lee; Sung Hwa Kim; Jae Geun Lee; Myoung Soo Kim; Kwang-Woong Lee; Dong Jin Joo
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

Review 5.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

Review 6.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.